Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.
暂无分享，去创建一个
S. Rafii | M. Mazumdar | Helen H. W. Chen | J. Knox | P. Christos | A. Siegel | Robert S. Brown | A. Ocean | A. Goldenberg | J. Mandeli | E. Popa | A. Weinberg | J. Schwartz | E. Cohen | D. Lehrer | S. Clark-Garvey